Details of the Drug

General Information of Drug (ID: DMAY0CG)

Drug Name

INN-108

Synonyms

5-(4-Carboxymethyl-Phenylazo)-2-Hydroxy-Benzoic Acid; UNII-QIU74LKJ78; QIU74LKJ78; Nobex-AA-004; SCHEMBL1636172; 5-((E)-(4-(Carboxymethyl)phenyl)azo)-2-hydroxy-benzoic acid; Benzeneacetic acid, 4-(2-(3-carboxy-4-hydroxyphenyl)diazenyl)-; 402934-69-4

Indication

Disease Entry	ICD 11	Status	REF
Ulcerative colitis	DD71	Phase 1	[1]
Inflammatory bowel disease	DD72	Discontinued in Phase 1/2	[2]
------------------------------------------------------------------------------------

Structure

3D MOL

2D MOL

Chemical Identifiers

Formula: C15H12N2O5
Canonical SMILES: C1=CC(=CC=C1CC(=O)O)N=NC2=CC(=C(C=C2)O)C(=O)O
InChI: 1S/C15H12N2O5/c18-13-6-5-11(8-12(13)15(21)22)17-16-10-3-1-9(2-4-10)7-14(19)20/h1-6,8,18H,7H2,(H,19,20)(H,21,22)
InChIKey: FNRNBCNUWGWVFO-UHFFFAOYSA-N

Cross-matching ID

PubChem CID: 135418366
CAS Number: 402934-69-4
TTD ID: D0BH9I

Repurposed Drugs (RPD)

Click to Jump to the Detailed RPD Information of This Drug

References

1	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2	Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800017232)